^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Vicineum (oportuzumab monatox)

    i
    Associations
    News
    Trials
    Company:
    CARISMA Therap, Cardinal Health, Hikma
    Drug class:
    Protein synthesis inhibitor, EpCAM-targeted antibody-drug conjugate
    Related drugs:
    Associations
    News
    Trials